Pregabalin

CAS 148553-50-8 43 current records 10 historicalSmall Molecule

Who holds supplier records for Pregabalin? 43 organisations hold a current record for Pregabalin: an active US FDA Type II Drug Master File or a CEP. A further 10 organisations have only historical (inactive) DMF filings. 33 of them hold a valid EU Certificate of Suitability (34 holder entries on the EDQM register, listed below). Recorded organisation countries for current records: India (33), China (7), Netherlands (1), Italy (1) and 1 other country (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Pregabalin: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/pregabalin

Reading the evidence

  • 43 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    33 of the 43 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 23 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

  • US product patents listed

    The latest patent listed in the FDA Orange Book for an approved product containing Pregabalin expires 2 May 2027. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.

Current records (43)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Pregabalin. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Pregabalin sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (34)

Certificates of Suitability on the EDQM register for Pregabalin, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 50 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. ShaoxingCN
CEP 2025-610 - Rev 01
Pregabalin, Process II
Nov 2026—
NINGBO MENOVO PHARMACEUTICAL CO., LTD. NingboCN
CEP 2026-264 - Rev 00
Pregabalin
Oct 2026—
HIKAL LIMITED BengaluruIN
CEP 2016-181 - Rev 04
Pregabalin
Oct 2026Inspected Nov 2025
Switzerland
MSN PHARMACHEM PRIVATE LIMITED SangareddyIN
CEP 2015-324 - Rev 03
Pregabalin, Route code-PB, crystalline form-1, micronised, non-micronised, milled and non-milled
Oct 2026—
HETERO DRUGS LIMITED HyderabadIN
CEP 2016-296 - Rev 02
Pregabalin
Sept 2026—
TAPI NL B.V. AmsterdamNL
CEP 2017-165 - Rev 03
Pregabalin
Sept 2026—
ZYDUS LIFESCIENCES LIMITED VadodaraIN
CEP 2019-019 - Rev 02
Pregabalin, Form-I
Aug 2026—
DONGBANG FUTURE TECH & LIFE CO., LTD. Hwaseong-SiKR
CEP 2018-148 - Rev 03
Pregabalin
Aug 2026—
DIVI'S LABORATORIES LIMITED HyderabadIN
CEP 2016-236 - Rev 01
Pregabalin
Aug 2026—
CTX LIFESCIENCES PRIVATE LIMITED SuratIN
CEP 2016-328 - Rev 05
Pregabalin
Aug 2026—
SARACA LABORATORIES LIMITED SangareddyIN
CEP 2022-439 - Rev 01
Pregabalin
Aug 2026Inspected Dec 2024
Belgium
MSN LIFE SCIENCES PRIVATE LIMITED KamareddyIN
CEP 2019-050 - Rev 01
Pregabalin, Route Code – PBN, Micronised and non-micronised
Jul 2026—
MATRIX PHARMACORP PRIVATE LIMITED SangareddyIN
CEP 2023-223 - Rev 03
Pregabalin, PEA Process
Jul 2026—
AURISCO PHARMACEUTICAL CO., LTD. TiantaiCN
CEP 2019-073 - Rev 03
Pregabalin, Process Code PREA, milled and sieved
Jul 2026Inspected Dec 2023
Germany
AALIDHRA PHARMACHEM PRIVATE LIMITED NandesariIN
CEP 2019-085 - Rev 04
Pregabalin
Jul 2026—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. TaizhouCN
CEP 2025-282 - Rev 01
Pregabalin, Process VI
Jul 2026Inspected May 2026
Italy
VIYASH SCIENTIFIC LIMITED HyderabadIN
CEP 2023-386 - Rev 02
Pregabalin
Jul 2026—
INTAS PHARMACEUTICALS LIMITED AhmedabadIN
CEP 2022-028 - Rev 03
Pregabalin, Process II, Milled, Form-I
Mar 2026—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
CEP 2016-220 - Rev 01
Pregabalin
Feb 2026—
CHROMO LABORATORIES INDIA PRIVATE LIMITED PashamylaramIN
CEP 2023-298 - Rev 00
Pregabalin
Feb 2026—
KOPRAN RESEARCH LABORATORIES LIMITED MumbaiIN
CEP 2018-080 - Rev 04
Pregabalin
Dec 2025—
DR. REDDY'S LABORATORIES LIMITED HyderabadIN
CEP 2020-024 - Rev 03
Pregabalin
Jul 2025—
ENANTI LABS PRIVATE LIMITED Anakapalli DistrictIN
CEP 2023-199 - Rev 00
Pregabalin
Apr 2025—
SRINI PHARMACEUTICALS PRIVATE LIMITED ChoutuppalIN
CEP 2018-169 - Rev 01
Pregabalin
Jan 2025Inspected Sept 2025
Sweden
ALMELO PRIVATE LIMITED Shabashpally VillageIN
CEP 2019-046 - Rev 04
Pregabalin
Dec 2024—
VASUDHA PHARMA CHEM LIMITED HyderabadIN
CEP 2018-072 - Rev 02
Pregabalin
Dec 2024—
LAURUS LABS LIMITED HyderabadIN
CEP 2017-266 - Rev 03
Pregabalin
Jul 2024—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2016-135 - Rev 01
Pregabalin
Jan 2024—
OPTIMUS DRUGS PRIVATE LIMITED HyderabadIN
R0-CEP 2021-126 - Rev 00
Pregabalin, Route code: OP-PGN
Mar 2023—
ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. LinhaiCN
R1-CEP 2016-189 - Rev 01
Pregabalin
Sept 2022—
MAPS LABORATORIES PRIVATE LIMITED RafaleshwarIN
R1-CEP 2015-370 - Rev 00
Pregabalin
Jul 2022—
Changzhou Pharmaceutical Factory Jiangsu ProvinceCN
R1-CEP 2016-141 - Rev 00
Pregabalin
Jun 2022—
MANGALAM DRUGS & ORGANICS LTD. MumbaiIN
R0-CEP 2020-016 - Rev 00
Pregabalin
May 2022—
INNOVARE LABS PRIVATE LIMITED VisakhapatnamIN
R0-CEP 2020-145 - Rev 00
Pregabalin
Nov 2021—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (10)

Organisations whose Type II DMFs for Pregabalin are no longer active. These show a past filing, not current supply.

Show all 10 historical records
  • India · Inactive DMF 34473 · filed Feb 2020
  • India · Inactive DMF 31929 · filed Dec 2017
  • India · Inactive DMF 30517 · filed Apr 2016
  • DIVI'S LABOTATORIES LTD
    Inactive DMF 28306 · filed May 2014
  • LUPIN MANUFACTURING SOLUTIONS LTD
    Inactive DMF 26673 · filed Jan 2013
  • India · Inactive DMF 26062 · filed May 2012
  • MYLAN LABORATORIES LTD
    Inactive DMF 25083 · filed Jun 2011
  • Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
    China · Inactive DMF 23342 · filed Nov 2009
  • India · Inactive DMF 22925 · filed Jul 2009
  • India · Inactive DMF 22330 · filed Dec 2008

US product patents and exclusivity

The FDA Orange Book lists patents and exclusivities for specific approved products (197 listed products contain Pregabalin). The latest listed patent expires 2 May 2027. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.

Overview

Pregabalin is a medication used to treat epilepsy, neuropathic pain, fibromyalgia, and generalized anxiety disorder. It works by decreasing the number of pain signals that are sent out by damaged nerves in the body.

Chemical identity

IUPAC name
(3S)-3-(aminomethyl)-5-methylhexanoic acid
Canonical SMILES
CC(C)C[C@@H](CC(=O)O)CN
InChIKey
AYXYPKUFHZROOJ-PEZBUJJGSA-N
Synonyms
Lyrica, Pregabalin oral solution, Pregabalin extended-release, Pregabalinum, Pregabalin

Therapeutic areas

NeurologyPain ManagementPsychiatry

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Pregabalin?

43 organisations hold an active US FDA Type II Drug Master File or a CEP for Pregabalin: CHANGZHOU PHARMACEUTICAL FACTORY (China), HIKAL LTD (India), Intas Pharmaceuticals Ltd. (India), MSN PHARMACHEM PRIVATE LTD (India), OPTIMUS DRUGS PRIVATE LTD (India), Zhejiang Bamboo Pharmaceuticals Co.,Ltd (China), Zydus Lifesciences Limited (India) and Alembic Pharmaceuticals Limited (India), and 35 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Pregabalin Drug Master Files are active?

CHANGZHOU PHARMACEUTICAL FACTORY (DMF 22223, 39164), HIKAL LTD (DMF 29688, 28663), Intas Pharmaceuticals Ltd. (DMF 27839, 36519), MSN PHARMACHEM PRIVATE LTD (DMF 25064, 22111), OPTIMUS DRUGS PRIVATE LTD (DMF 30968, 34934), Zhejiang Bamboo Pharmaceuticals Co.,Ltd (DMF 38102, 43043), Zydus Lifesciences Limited (DMF 27792, 32520) and Alembic Pharmaceuticals Limited (DMF 24292) and 25 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Pregabalin records mean?

10 organisations have only inactive Type II DMFs for Pregabalin. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Pregabalin have a European Certificate of Suitability?

Yes. 33 organisations hold a valid CEP for Pregabalin on the EDQM register, including ZHEJIANG BAMBOO PHARMACEUTICALS CO.,LTD. Shaoxing (CN), NINGBO MENOVO PHARMACEUTICAL CO., LTD. Ningbo (CN), HIKAL LIMITED Bengaluru (IN), MSN PHARMACHEM PRIVATE LIMITED Sangareddy (IN), HETERO DRUGS LIMITED Hyderabad (IN) and TAPI NL B.V. Amsterdam (NL) and 28 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

Does the FDA Orange Book list patents for products containing Pregabalin?

Yes. The latest patent listed for an approved US product containing Pregabalin expires 2 May 2027, across 197 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.

How do I qualify a Pregabalin supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Pregabalin?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.